TP53 and oral cavity squamous cell carcinoma: Combined with report indicating that PD-L1 was correlated with p53 in NSCLC and oral squamous cell carcinoma,14,15 EBV insertion can be assumed to promote the expression of BART5-3P, consequently inhibiting p53 and PD-L1.